Iteos Therapeutics (ITOS) PE Ratio Chart - ITOS Stock Price to …

Feb 28, 2022 · Get the pe ratio charts for Iteos Therapeutics (ITOS). 100% free, no signups. Get 20 years of historical pe ratio charts for ITOS stock and other companies. Tons of financial …

100%
OFF

Iteos Therapeutics (ITOS) PE Ratio Chart - ITOS Stock Price To …

1 week from now

Feb 28, 2022 · Get the pe ratio charts for Iteos Therapeutics (ITOS). 100% free, no signups. Get 20 years of historical pe ratio charts for ITOS stock and other companies. Tons of financial …

financecharts.com

12%
OFF

ITeos Therapeutics PE Ratio Trends | YCharts

1 week from now

ITeos Therapeutics Inc (ITOS) 8.55 +0.01 (+0.12% ... ITeos Therapeutics PE Ratio. PE Ratio Chart. Historical PE Ratio Data. View and export this data back to 2021. ... The Price to …

ycharts.com

100%
OFF

Iteos Therapeutics (ITOS) Average PE Ratio Chart - ITOS Stock …

1 week from now

Get the average pe ratio charts for Iteos Therapeutics (ITOS). 100% free, no signups. Get 20 years of historical average pe ratio charts for ITOS stock and other companies. Tons of …

financecharts.com

14%
OFF

ITeos Therapeutics PE Ratio (3y Median) - YCharts

1 week from now

In depth view into ITeos Therapeutics PE Ratio (3y Median) including historical data from 2020, charts and stats. ... ITeos Therapeutics Inc (ITOS) 10.18-0.33 (-3.14%) USD | NASDAQ | Oct …

ycharts.com

100%
OFF

Iteos Therapeutics (ITOS) Stock - Research | Financials | Charts ...

1 week from now

Research Iteos Therapeutics (ITOS) stock. Get 20 year charts on every key metric for ITOS. Is Iteos Therapeutics stock a buy or sell? 100% free analysis on ITOS, no signups required. ...

financecharts.com

$283.84
OFF

ITeos Therapeutics (NASDAQ:ITOS) Earns "Buy" Rating From

1 week from now

1 day ago · The stock has a market capitalization of $283.84 million, a PE ratio of -2.47 and a beta of 1.39. The company has a fifty day moving average of $8.08 and a 200-day moving …

marketbeat.com

2%
OFF

ITeos Therapeutics: Promising Phase 2 Data Boosts Buy Rating On …

1 week from now

1 day ago · These factors collectively support the Buy rating for iTeos Therapeutics. According to TipRanks , Ramakanth is a 4-star analyst with an average return of 7.2% and a 38.48% …

businessinsider.com

FAQs about Iteos Therapeutics (ITOS) PE Ratio Chart - ITOS Stock Price to … Coupon?

How much does iTeos Therapeutics (ITOS) earn?

iTeos Therapeutics (NASDAQ:ITOS) has a recorded net income of $96.65 million. ITOS has generated -$0.80 earnings per share over the last four quarters. What is iTeos Therapeutics's EPS forecast for next year? ...

How much is iTeos Therapeutics stock now?

iTeos Therapeutics' stock was trading at $10.95 at the start of the year. Since then, ITOS stock has decreased by 33.2% and is now trading at $7.32. How were iTeos Therapeutics' earnings last quarter? iTeos Therapeutics, Inc. (NASDAQ:ITOS) issued its quarterly earnings results on Tuesday, November, 12th. ...

Should you buy iTeos Therapeutics (ITOS)?

Your Privacy Choices Ad Terms Feedback iTeos Therapeutics (ITOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. ...

Who is iTeos Therapeutics?

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer. ...